Histological margin assessment for breast ductal carcinoma in situ: precision and implications
- PMID: 14657957
- DOI: 10.1038/modpathol.3800019
Histological margin assessment for breast ductal carcinoma in situ: precision and implications
Abstract
Local recurrence after lumpectomy for ductal carcinoma in situ (DCIS) is a major concern and is related to residual disease in the breast. We studied the predictive value of lumpectomy margins for residual DCIS and compared our results and pathological processing techniques with those published in the literature. Margin status was determined for 89 patients with screen-detected DCIS who had lumpectomy and re-excision, for the presence and extent of residual disease. Margin width was defined as the narrowest distance between tumor and any inked margin or, where margins were positive, classified into focal involvement (<1 mm of the inked surface involved), minimal (>or=1<15 mm) and extensive (>or=15 mm). The amount of residual tumor was quantified according to the number of ducts involved with tumor: small (fewer than 10 ducts) or large (10 or more ducts) residuum. The initial margin status was a significant predictor for the presence of residual tumor in re-excision specimens (P=0.006). There was residual tumor in 44 and 45% of close non-involved (>1 and <or=1 mm width) margins, 67% of focally, 71% of moderately and 94% of extensively positive margins. The pathologic tumor size was also a predictor for the presence of residual tumor with 27, 68 and 74% of lesions measuring <or=10, 11-25, >25 mm,respectively, showing residual disease. The presence of residual tumor was not significantly related to age, mammographic appearance, nuclear grade or intraductal necrosis. The initial margin status was found to predict for the amount of residual tumor. With careful margin assessment, margin status after lumpectomy for DCIS can be used to predict for the presence and amount of residual tumor in the breast and is a guide to further management decisions. A standard for margin status reporting and pathological processing of screen-detected DCIS in situ lesions will help in the interpretation of data from different institutions.
Similar articles
-
The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast.Cancer. 2002 Apr 1;94(7):1917-24. doi: 10.1002/cncr.10460. Cancer. 2002. PMID: 11932892
-
Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis.Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):722-30. doi: 10.1016/j.ijrobp.2004.04.012. Int J Radiat Oncol Biol Phys. 2004. PMID: 15465188
-
The value of breast lumpectomy margin assessment as a predictor of residual tumor burden.Int J Radiat Oncol Biol Phys. 1997 May 1;38(2):291-9. doi: 10.1016/s0360-3016(97)82498-4. Int J Radiat Oncol Biol Phys. 1997. PMID: 9226315
-
Margins in breast cancer: How much is enough?Cancer. 2018 Apr 1;124(7):1335-1341. doi: 10.1002/cncr.31221. Epub 2018 Jan 16. Cancer. 2018. PMID: 29338088 Free PMC article. Review.
-
Margin status after breast-conserving treatment of breast cancer: how much free margin is enough?J Surg Oncol. 2008 Dec 15;98(8):585-7. doi: 10.1002/jso.21038. J Surg Oncol. 2008. PMID: 19072849 Review.
Cited by
-
The chemokine receptor CX₃CR1 is directly involved in the arrest of breast cancer cells to the skeleton.Breast Cancer Res. 2011 Sep 20;13(5):R91. doi: 10.1186/bcr3016. Breast Cancer Res. 2011. PMID: 21933397 Free PMC article.
-
Comparative analysis of margin status in breast conservation surgery and its correlation with subsequent re-excision findings.Pathologica. 2019 Mar;111(1):31-36. doi: 10.32074/1591-951X-64-18. Pathologica. 2019. PMID: 31217620 Free PMC article.
-
Photoacoustic and fluorescence image-guided surgery using a multifunctional targeted nanoprobe.Ann Surg Oncol. 2014 May;21(5):1602-9. doi: 10.1245/s10434-014-3541-9. Epub 2014 Feb 20. Ann Surg Oncol. 2014. PMID: 24554061 Free PMC article.
-
uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.Theranostics. 2013 Dec 17;4(1):106-18. doi: 10.7150/thno.7409. eCollection 2013. Theranostics. 2013. PMID: 24396518 Free PMC article.
-
Occurrence of Residual Cancer Within Re-excisions After Subcutaneous Mastectomy of Invasive Breast Cancer and Ductal Carcinoma In Situ - A Retrospective Analysis.In Vivo. 2020 Jul-Aug;34(4):2015-2019. doi: 10.21873/invivo.12000. In Vivo. 2020. PMID: 32606175 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical